Starting Dose of Basal Insulin
For insulin-naive patients with type 2 diabetes, start basal insulin at 10 units once daily OR 0.1-0.2 units/kg body weight per day, administered at the same time each day. 1, 2, 3, 4
Standard Dosing Algorithm
Type 2 Diabetes (Insulin-Naive)
- Standard starting dose: 10 units once daily OR 0.1-0.2 units/kg/day 1, 2, 3, 4
- Conservative approach (high-risk patients): Use 0.1 units/kg/day (or 10 units, whichever is lower) for patients with history of hypoglycemia, elderly >65 years, renal impairment, or poor oral intake 2, 3
- Severe hyperglycemia (A1C ≥9%, glucose ≥300-350 mg/dL): Consider higher starting doses of 0.3-0.5 units/kg/day as total daily dose, using basal-bolus regimen from the outset 2, 3
Type 1 Diabetes
- Total daily insulin requirement: 0.4-1.0 units/kg/day, with 0.5 units/kg/day typical for metabolically stable patients 1, 2, 3
- Basal insulin component: Approximately 40-60% of total daily dose (roughly 0.2-0.3 units/kg/day) 2, 3
- Remaining 50-60%: Given as prandial insulin divided among meals 2, 3
Dose Adjustments for Special Populations
Patients with Renal Impairment
- CKD Stage 5 (type 2 diabetes): Reduce total daily insulin dose by 50% 2, 3
- CKD Stage 5 (type 1 diabetes): Reduce total daily insulin dose by 35-40% 2, 3
- eGFR <45 mL/min/1.73 m²: Titrate conservatively to avoid hypoglycemia 2
- Specific starting dose: 0.1 units/kg/day (or 0.114 units/kg/day based on research data) 2, 5
High-Risk Patients Requiring Lower Doses
- Elderly (>65 years): Maximum starting dose 0.1 units/kg/day 2, 3
- History of hypoglycemia: 0.1 units/kg/day (or 10 units, whichever is lower) 2
- Poor oral intake or acute illness: 0.1-0.25 units/kg/day 2, 3
- Patients with retinopathy: 0.120 units/kg/day 5
Gender and Medication Considerations
- Women: Slightly lower starting dose of 0.135 units/kg/day may be appropriate 5
- Patients on sulfonylureas: Consider 0.132 units/kg/day 5
Titration Protocol
Standard Titration Schedule
- Increase by 2 units every 3 days if fasting glucose is 140-179 mg/dL 1, 2, 3
- Increase by 4 units every 3 days if fasting glucose is ≥180 mg/dL 1, 2, 3
- Target fasting glucose: 80-130 mg/dL 1, 2, 3
Conservative Titration (High-Risk Patients)
- Increase by 2 units every 3 days only (avoid the more aggressive 4-unit increment) 2
- If hypoglycemia occurs: Immediately reduce dose by 10-20% 1, 2, 3
Critical Threshold Warning
When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, add prandial insulin rather than continuing to escalate basal insulin alone. 1, 2, 3
Signs of Overbasalization
- Basal dose >0.5 units/kg/day 2, 3
- Bedtime-to-morning glucose differential ≥50 mg/dL 2, 3
- Hypoglycemia episodes 2, 3
- High glucose variability 2, 3
Adding Prandial Insulin
- Starting dose: 4 units before the largest meal OR 10% of basal dose 2, 3
- Titrate: By 1-2 units or 10-15% every 3 days based on postprandial glucose 2, 3
Foundation Therapy
Continue metformin unless contraindicated (eGFR <30 mL/min/1.73 m²), as it reduces total insulin requirements and provides complementary glucose-lowering effects. 1, 2, 3
Monitoring Requirements
- Daily fasting blood glucose monitoring is essential during titration 1, 2, 3
- Reassess every 3 days during active titration 2
- Assess adequacy at every clinical visit 2, 3
- Check A1C every 3 months during intensive titration 3
Common Pitfalls to Avoid
- Do not use standard starting doses (0.2 units/kg/day) in high-risk patients with history of hypoglycemia, elderly, or renal impairment 2, 3
- Do not delay dose reduction when hypoglycemia occurs 2
- Never use sliding scale insulin as monotherapy 2, 3
- Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without adding prandial coverage 1, 2, 3
- Do not discontinue metformin when starting insulin unless contraindicated 1, 2, 3
Practical Calculation Formula
A simplified formula derived from Japanese clinical data suggests: 5
Optimal daily dose at 24 weeks = starting dose (0.15 × weight in kg) + incremental dose (baseline HbA1c - target HbA1c + 2)
However, this formula requires validation and should be adjusted downward for high-risk populations as outlined above. 5